Liver growth factor treatment restores cell-extracellular matrix balance in resistance arteries and improves left ventricular hypertrophy in SHR

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 301, Issue 3, 2011, Pages

  Victoria Conde, M ^a   Carmen Gonzalez, M ^a   Quintana Villamandos, Begoña ^b   Abderrahim, Fatima ^a   Briones, Ana M ^a   Condezo Hoyos, Luis ^a   Regadera, Javier ^a   Susin, Cristina ^a   de Diego, Jose J Gomez ^c   Delgado Baeza, Emilio ^a   Diaz Gil, Juan J ^d   Arribas, Silvia M ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Servicio de Anestesia y Reanimacion   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

Intramyocardial arteries; Left ventricular hypertrophy; Mesenteric resistance arteries; Nitric oxide; Vascular remodeling

Indexed keywords

COLLAGEN; ELASTIN; FIBRONECTIN; GROWTH FACTOR; LIVER GROWTH FACTOR; NITRIC OXIDE; PARAFFIN; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTERIAL PRESSURE; ARTERY RESISTANCE; ARTICLE; CAROTID ARTERY; CELL DENSITY; CELL PROLIFERATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG MECHANISM; ECHOCARDIOGRAPHY; EXTRACELLULAR MATRIX; GEOMETRY; HEART; HEART LEFT VENTRICLE HYPERTROPHY; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; MALE; MECHANICS; MICROSCOPY; MYOGRAPHY; NONHUMAN; PLOIDY; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIHYPERTENSIVE AGENTS; BILIRUBIN; BLOOD PRESSURE; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; CORONARY VESSELS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELASTIN; EXTRACELLULAR MATRIX; FIBRONECTINS; FIBROSIS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOHISTOCHEMISTRY; MALE; MESENTERIC ARTERIES; MICROSCOPY, CONFOCAL; MICROSCOPY, POLARIZATION; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; MYOCYTES, SMOOTH MUSCLE; MYOGRAPHY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RATS, INBRED SHR; RATS, INBRED WKY; SERUM ALBUMIN; SUPEROXIDES; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS; VENTRICULAR REMODELING;

EID: 80052341421     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00886.2010     Document Type: Article

References (72)

1. Agabiti-Rosei E, Heagerty AM, Rizzoni D. Effects of antihypertensive treatment on small artery remodelling. J Hypertens 27: 1107-1114, 2009.
2. Alvarez de Sotomayor M, Bueno R, Perez-Guerrero C, Herrera MD. Effect of L-carnitine and propionyl-L-carnitine on endothelial function of small mesenteric arteries from SHR. J Vasc Res 44: 354-364, 2007.
3. Alvarez Y, Perez-Giron JV, Hernanz R, Briones AM, Garcia-Redondo A, Beltran A, Alonso MJ, Salaices M. Losartan reduces the increased participation of cyclooxygenase-2-derived products in vascular responses of hypertensive rats. J Pharmacol Exp Ther 321: 381-388, 2007.
4. Arribas SM, Briones AM, Bellingham C, Gonzalez MC, Salaices M, Liu K, Wang Y, Hinek A. Heightened aberrant deposition of hardwearing elastin in conduit arteries of prehypertensive SHR is associated with increased stiffness and inward remodeling. Am J Physiol Heart Circ Physiol 295: H2299-H2307, 2008.
5. Arribas SM, Daly CJ, Gonzalez MC, McGrath JC. Imaging the vascular wall using confocal microscopy. J Physiol 584: 5-9, 2007.
6. Arribas SM, Daly CJ, McGrath IC. Measurements of vascular remodeling by confocal microscopy. Methods Enzymol 307: 246-273, 1999.
7. Arribas SM, Hermida C, Gonzalez MC, Wang Y, Hinek A. Enhanced survival of vascular smooth muscle cells accounts for heightened elastin deposition in arteries of neonatal SHR. Exp Physiol 95: 550-560, 2010.
8. Arribas SM, Hillier C, Gonzalez C, McGrory S, Dominiczak AF, McGrath JC. Cellular aspects of vascular remodeling in hypertension revealed by confocal microscopy. Hypertension 30: 1455-1464, 1997.
9. Bezerra DG, Mandarim-de-Lacerda C. Beneficial effect of simvastatin and pravastatin treatment on adverse cardiac remodelling and glomeruli loss in spontaneously hypertensive rats. Clin Sci (Lond) 108: 349-355, 2005.
10. Boluyt MO, Bing OH, Lakatta EG. The ageing spontaneously hypertensive rat as a model of the transition from stable compensated hypertrophy to heart failure. Eur Heart J 16, Suppl N: 19-30, 1995.
11. Boumaza S, Arribas SM, Osborne-Pellegrin M, McGrath JC, Laurent S, Lacolley P, Challande P. Fenestrations of the carotid internal elastic lamina and structural adaptation in stroke-prone spontaneously hypertensive rats. Hypertension 37: 1101-1107, 2001.
12. Briones AM, Arribas SM, Salaices M. Role of extracellular matrix in vascular remodeling of hypertension. Curr Opin Nephrol Hypertens 19: 187-194, 2000.
13. Briones AM, Gonzalez JM, Somoza B, Giraldo J, Daly CJ, Vila E, Gonzalez MC, McGrath JC, Arribas SM. Role of elastin in spontaneously hypertensive rat small mesenteric artery remodelling. J Physiol 552: 185-195, 2003.
14. Briones AM, Rodriguez-Criado N, Hernanz R, Garcia-Redondo AB, Rodrigues-Diez RR, Alonso MJ, Egido J, Ruiz-Ortega M, Salaices M. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. Hypertension 54: 142-149, 2009.
15. Chan YS, Wong TM. Relationship of rostral ventrolateral medullary neurons and angiotensin in the central control of blood pressure. Biol Signals 4: 133-141, 1995.
16. Clark JE, Foresti R, Sarathchandra P, Kaur H, Green CJ, Motterlini R. Heme oxygenase-1-derived bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol 278: H643-H651, 2000.
17. Conde MV, Marin J, Balfagon G. Superoxide anion and K+ channels mediate electrical stimulation-induced relaxation in the rat basilar artery. Eur J Pharmacol 372: 179-186, 1999.
18. Condezo-Hoyos L, Abderrahim F, Conde MV, Susin C, Diaz-Gil JJ, Gonzalez MC, Arribas SM. Antioxidant activity of liver growth factor, a bilirubin covalently bound to albumin. Free Radic Biol Med 46: 656-662, 2009.
19. Dayan D, Hiss Y, Hirshberg A, Bubis JJ, Wolman M. Are the polarization colors of picrosirius red-stained collagen determined only by the diameter of the fibers? Histochemistry 93: 27-29, 1989.
20. Devereux RB. Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension 9: II19-II26, 1987.
21. Diaz-Gil JJ, Escartin P, Garcia-Canero R, Trilla C, Veloso JJ, Sanchez G, Moreno-Caparros A, Enrique de Salamanca C, Lozano R, Gavilanes JG. Purification of a liver DNA-synthesis promoter from plasma of partially hepatectomized rats. Biochem J 235: 49-55, 1986.
22. Diaz-Gil JJ, Garcia-Monzon C, Rua C, Martin-Sanz P, Cereceda RM, Miquilena-Colina ME, Machin C, Fernandez-Martinez A, Garcia-Canero R. The anti-fibrotic effect of liver growth factor is associated with decreased intrahepatic levels of matrix metalloproteinases 2 and 9 and transforming growth factor beta 1 in bile duct-ligated rats. Histol Histopathol 23: 583-591, 2008.
23. Diaz-Gil JJ, Garcia-Monzon C, Rua C, Martin-Sanz P, Cereceda RM, Miquilena-Colina ME, Machin C, Fernandez-Martinez A, Garcia-Canero R. Liver growth factor antifibrotic activity in vivo is associated with a decrease in activation of hepatic stellate cells Histol. Histopathol 24: 473-479, 2009.
24. Diaz-Gil JJ, Gavilanes JG, Garcia-Canero R, Garcia-Segura JM, Santamaria L, Trilla C, Martin AM, Guerra MA, Garcia-Escandon F, Iniguez JA. Liver growth factor purified from human plasma is an albumin-bilirubin complex. Mol Biol Med 6: 197-207, 1989.
25. Diaz-Gil JJ, Gavilanes JG, Sanchez G, Garcia-Canero R, Garcia-Segura JM, Santamaria L, Trilla C, Escartin P. Identification of a liver growth factor as an albumin-bilirubin complex. Biochem J 243: 443-448, 1987.
26. Diaz-Gil JJ, Munoz J, Albillos A, Rua C, Machin C, Garcia-Canero R, Cereceda RM, Guijarro MC, Trilla C, Escartin P. Improvement in liver fibrosis, functionality and hemodynamics in CCI4-cirrhotic rats after injection of the Liver Growth Factor. J Hepatol 30: 1065-1072, 1999.
27. Diaz-Gil JJ, Rua C, Machin C, Cereceda RM, Garcia-Canero R, de Foronda M, Perez de Diego J, Trilla C, Escartin P. Hepatic growth induced by injection of the liver growth factor into normal rats. Growth Regul 4: 113-122, 1994.
28. Dickhout JG, Lee RM. Blood pressure and heart rate development in young spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 274: H794-H800, 1998.
29. Fernandes-Santos C, de Souza Mendonca L, Mandarim-de-Lacerda C. A Favorable cardiac and aortic remodeling in olmesartan-treated spontaneously hypertensive rats. Heart Vessels 24: 219-227, 2009.
30. Garcia-Redondo AB, Briones AM, Avendano MS, Hernanz R, Alonso MJ, Salaices M. Losartan and tempol treatments normalize the increased response to hydrogen peroxide in resistance arteries from hypertensive rats. J Hypertens 27: 1814-1822, 2009.
31. Gerdts E, Cramariuc D, de Simone G, Wachtell K, Dahlof B, Devereux RB. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr 9: 809-815, 2008.
32. Gomez-Roso M, Montero MJ, Carron R, Sevilla MA. Cardiovascular changes in spontaneously hypertensive rats are improved by chronic treatment with zofenopril. Br J Pharmacol 158: 1911-1921, 2009.
33. Gonzalez JM, Briones AM, Somoza B, Daly CJ, Vila E, Starcher B, McGrath JC, Gonzalez MC, Arribas SM. Postnatal alterations in elastic fiber organization precede resistance artery narrowing in SHR. Am J Physiol Heart Circ Physiol 291: H804-H812, 2006.
34. Gonzalez JM, Somoza B, Conde MV, Fernandez-Alfonso MS, Gonzalez MC, Arribas SM. Hypertension increases middle cerebral artery resting tone in spontaneously hypertensive rats: role of tonic vasoactive factor availability. Clin Sci (Lond) 114: 651-659, 2008.
35. Gonzalo-Gobernado R, Reimers D, Herranz AS, Diaz-Gil JJ, Osuna C, Asensio MJ, Baena S, Rodriguez-Serrano M, Bazan E. Mobilization of neural stem cells and generation of new neurons in 6-OHDA-lesioned rats by intracerebroventricular infusion of liver growth factor. J Histochem Cytochem 57: 491-502, 2009.
36. Gonzalo-Gobernado R, Reimers D, Herranz AS, Rodriguez-Serrano M, Asensio MJ, Luna B, Diaz-Gil JJ, Bazan E. Actividad neurotrófica del factor de crecimiento de hígado en un modelo experimental de enfermedad de Parkinson. Congreso de la SENC Tarragona España In press.
37. Gradman AH, Alfayoumi F. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease. Prog Cardiovasc Dis 48: 326-341, 2006.
38. Hale TM, Shoichet MJ, Bushfield TL, Adams MA. Time course of vascular structural changes during and after short-term antihypertensive treatment. Hypertension 42: 171-176, 2003.
39. Intengan HD, Thibault G, Li JS, Schiffrin EL. Resistance artery mechanics, structure, and extracellular components in spontaneously hypertensive rats: effects of angiotensin receptor antagonism and converting enzyme inhibition. Circulation 100: 2267-2275, 1999.
40. Junqueira LC, Bignolas G, Brentani RR. Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J 11: 447-455, 1979.
41. Kawamura K, Ishikawa K, Wada Y, Kimura S, Matsumoto H, Kohro T, Itabe H, Kodama T, Maruyama Y. Bilirubin from heme oxygenase-1 attenuates vascular endothelial activation and dysfunction. Arterioscler Thromb Vasc Biol 25: 155-160, 2005.
42. Kokubo M, Uemura A, Matsubara T, Murohara T. Noninvasive evaluation of the time course of change in cardiac function in spontaneously hypertensive rats by echocardiography. Hypertens Res 28: 601-609, 2005.
43. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114: 345-352, 1991.
44. Kubo M, Umemoto S, Fujii K, Itoh S, Tanaka M, Kawahara S, Matsuzaki M. Effects of angiotensin II type 1 receptor antagonist on smooth muscle cell phenotype in intramyocardial arteries from spontaneously hypertensive rats. Hypertens Res 27: 685-693, 2004.
45. Laurant P, Touyz RM, Schiffrin EL. Effect of pressurization on mechanical properties of mesenteric small arteries from spontaneously hypertensive rats. J Vasc Res 34: 117-125, 1997.
46. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322: 1561-1566, 1990.
47. Martinez-Galan L, del Puerto-Nevado L, Perez-Rial S, Diaz-Gil JJ, Gonzalez-Mangado N, Peces-Barba G. Liver growth factor improves pulmonary fibrosis secondary to cadmium administration in mice. Arch Bronconeumol 46: 20-26, 2000.
48. Mathiassen ON, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe O, Mulvany MJ, Christensen KL. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens 25: 1021-1026, 2007.
49. Meziani F, Kremer H, Tesse A, Baron-Menguy C, Mathien C, Mostefai HA, Carusio N, Schneider F, Asfar P, Andriantsitohaina R. Human serum albumin improves arterial dysfunction during early resuscitation in mouse endotoxic model via reduced oxidative and nitrosative stresses. Am J Pathol 171: 1753-1761, 2007.
50. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, pharmacology. Pharmacol Rev 43: 109-142, 1991.
51. Perez-Crespo M, Pericuesta E, Perez-Cerezales S, Arenas MI, Lobo MV, Diaz-Gil JJ, Gutierrez-Adan A. Effect of liver growth factor on both testicular regeneration and recovery of spermatogenesis in busulfantreated mice (Abstract). Reprod Biol Endocrinol 9: 21, 2011.
52. Reimers D, Herranz AS, Diaz-Gil JJ, Lobo MV, Paino CL, Alonso R, Asensio MJ, Gonzalo-Gobernado R, Bazan E. Intrastriatal infusion of liver growth factor stimulates dopamine terminal sprouting and partially restores motor function in 6-hydroxydopamine-lesioned rats. J Histochem Cytochem 54: 457-465, 2006.
53. Reiter RJ, Manchester LC, Fuentes-Broto L, Tan DX. Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin. J Hypertens 28, Suppl 1: S7-S12, 2000.
54. Rizzoni D, Paiardi S, Rodella L, Porteri E, De Ciuceis C, Rezzani R, Boari GE, Zani F, Miclini M, Tiberio GA, Giulini SM, Rosei CA, Bianchi R, Rosei EA. Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism. J Clin Endocrinol Metab 91: 2638-2642, 2006.
55. Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E. Prognostic significance of small-artery structure in hypertension. Circulation 108: 2230-2235, 2003.
56. Roche M, Rondeau P, Singh NR, Tarnus E, Bourdon E. The antioxidant properties of serum albumin. FEBS Lett 582: 1783-1787, 2008.
57. Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens 21: 500-508, 2008.
58. Schnitzer JE, Sung A, Horvat R, Bravo J. Preferential interaction of albumin-binding proteins, gp30 and gp18, with conformationally modified albumins. Presence in many cells and tissues with a possible role in catabolism. J Biol Chem 267: 24544-24553, 1992.
59. Senior AE, Weber J, Nadanaciva S. The catalytic transition state in ATP synthase. J Bioenerg Biomembr 32: 523-529, 2000.
60. Slama M, Ahn J, Peltier M, Maizel J, Chemla D, Varagic J, Susic D, Tribouilloy C, Frohlich ED. Validation of echocardiographic and Doppler indexes of left ventricular relaxation in adult hypertensive and normotensive rats. Am J Physiol Heart Circ Physiol 289: H1131-H1136, 2005.
61. Smith TL, Hutchins PM. Central hemodynamics in the developmental stage of spontaneous hypertension in the unanesthetized rat. Hypertension 1: 508-517, 1979.
62. Somoza B, Abderrahim F, Gonzalez JM, Conde MV, Arribas SM, Starcher B, Regadera J, Fernandez-Alfonso MS, Diaz-Gil JJ, Gonzalez MC. Short-term treatment of spontaneously hypertensive rats with liver growth factor reduces carotid artery fibrosis, improves vascular function, and lowers blood pressure. Cardiovasc Res 69: 764-771, 2006.
63. Somoza B, Gonzalez C, Cachofeiro V, Lahera V, Fernandez-Alfonso MS. Chronic L-arginine treatment reduces vascular smooth muscle cell hypertrophy through cell cycle modifications in spontaneously hypertensive rats. J Hypertens 22: 751-758, 2004.
64. Stocker R, Glazer AN, Ames BN. Antioxidant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA 84: 5918-5922, 1987.
65. Surra JC, Guillén N, Barranquero C, Arbonés-Mainar JM, Navarro MA, Gascón S, Arnal C, Godino J, Guzmán MA, Díaz-Gil JJ, Osada J. Sex-dependent effect of liver growth factor on atherosclerotic lesions and fatty liver disease in apolipoprotein E knockout mice. Histol Histopathol 25: 609-618, 2010.
66. Taniyama Y, Griendling KK. Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42: 1075-1081, 2003.
67. Tiruppathi C, Song W, Bergenfeldt M, Sass P, Malik AB. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway. J Biol Chem 272: 25968-25975, 1997.
68. Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 139: 191-202, 2003.
69. Virdis A, Colucci R, Versari D, Ghisu N, Fornai M, Antonioli L, Duranti E, Daghini E, Giannarelli C, Blandizzi C, Taddei S, Del Tacca M. Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids. Hypertension 53: 1008-1016, 2009.
70. Virdis A, Neves MF, Amiri F, Touyz RM, Schiffrin EL. Role of NAD(P)H oxidase on vascular alterations in angiotensin II-infused mice. J Hypertens 22: 535-542, 2004.
71. Wong LC, Langille BL. Developmental remodeling of the internal elastic lamina of rabbit arteries: effect of blood flow. Circ Res 78: 799-805, 1996.
72. Wu TW, Wu J, Li RK, Mickle D, Carey D. Albumin-bound bilirubins protect human ventricular myocytes against oxyradical damage. Biochem Cell Biol 69: 683-688, 1991.